212 related articles for article (PubMed ID: 23889214)
21. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care.
Nishigori C; Nakano E; Masaki T; Ono R; Takeuchi S; Tsujimoto M; Ueda T
Photochem Photobiol; 2019 Jan; 95(1):140-153. PubMed ID: 30565713
[TBL] [Abstract][Full Text] [Related]
22. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
[TBL] [Abstract][Full Text] [Related]
23. [Xeroderma pigmentosum].
Ueda M; Ichihashi M
Nihon Rinsho; 1995 Nov; 53(11):2815-20. PubMed ID: 8538050
[TBL] [Abstract][Full Text] [Related]
24. [Neurological abnormalities in xeroderma pigmentosum].
El Fékih N; Fredj M; Aounallah-Skhiri H; Fazaa B; Zghal M; Ridha Kamoun M
Rev Neurol (Paris); 2009 Nov; 165(11):967-70. PubMed ID: 19268336
[TBL] [Abstract][Full Text] [Related]
25. Neurological symptoms and natural course of xeroderma pigmentosum.
Anttinen A; Koulu L; Nikoskelainen E; Portin R; Kurki T; Erkinjuntti M; Jaspers NG; Raams A; Green MH; Lehmann AR; Wing JF; Arlett CF; Marttila RJ
Brain; 2008 Aug; 131(Pt 8):1979-89. PubMed ID: 18567921
[TBL] [Abstract][Full Text] [Related]
26. Three school-age cases of xeroderma pigmentosum variant type.
Ono R; Masaki T; Takeuchi S; Shimizu A; Tanioka M; Kambe N; Matsue H; Kamide R; Nishigori C
Photodermatol Photoimmunol Photomed; 2013 Jun; 29(3):132-9. PubMed ID: 23651273
[TBL] [Abstract][Full Text] [Related]
27. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
28. Association of xeroderma pigmentosum with thrombasthenia.
Hasanoğlu A; Gücüyener K; Tümer L; Gürsel T
Turk J Pediatr; 1996; 38(2):261-4. PubMed ID: 8701496
[TBL] [Abstract][Full Text] [Related]
29. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study.
Bhutto AM; Shaikh A; Nonaka S
Br J Dermatol; 2005 Mar; 152(3):545-51. PubMed ID: 15787826
[TBL] [Abstract][Full Text] [Related]
30. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.
Bradford PT; Goldstein AM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Pike KM; Raziuddin A; Plona TM; DiGiovanna JJ; Tucker MA; Kraemer KH
J Med Genet; 2011 Mar; 48(3):168-76. PubMed ID: 21097776
[TBL] [Abstract][Full Text] [Related]
31. Xeroderma pigmentosum: heterogeneous syndrome and model for UV carcinogenesis.
Jung EG
Bull Cancer; 1978; 65(3):315-21. PubMed ID: 719183
[TBL] [Abstract][Full Text] [Related]
32. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
33. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
[TBL] [Abstract][Full Text] [Related]
34. Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew.
Christen-Zaech S; Imoto K; Khan SG; Oh KS; Tamura D; Digiovanna JJ; Boyle J; Patronas NJ; Schiffmann R; Kraemer KH; Paller AS
Arch Dermatol; 2009 Nov; 145(11):1285-91. PubMed ID: 19917958
[TBL] [Abstract][Full Text] [Related]
35. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
36. [Genetic complementation group analysis of xeroderma pigmentosum patients in China].
Qiang K; Zhang Y; Han Z; You Y; Jiao H; Xu F; Xu P; Sun L; Ho Z; Peng L; Yu Z; Ikenage M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):285-9. PubMed ID: 10514532
[TBL] [Abstract][Full Text] [Related]
37. [Progress of research on xeroderma pigmentosum].
Tanaka K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1095-103. PubMed ID: 2190536
[TBL] [Abstract][Full Text] [Related]
38. Differences in peripheral neuropathy in xeroderma pigmentosum complementation groups A and D as evaluated by nerve conduction studies.
Lehky TJ; Sackstein P; Tamura D; Quezado M; Wu T; Khan SG; Patronas NJ; Wiggs E; Brewer CC; DiGiovanna JJ; Kraemer KH
BMC Neurol; 2021 Oct; 21(1):393. PubMed ID: 34627174
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of xeroderma pigmentosum (XP); variability and stability within and between the complementation groups C, D, E, I and variants.
Jung EG; Bohnert E; Fischer E
Photodermatol; 1986 Jun; 3(3):125-32. PubMed ID: 3748852
[TBL] [Abstract][Full Text] [Related]
40. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
